EURONEXT:IVA
Inventiva Pharma
- Stock
locale
Francemarket
STOCKSindustry
Biotechnologywebsite
www.inventivapharma.comipo date
Feb 15, 2017
Inventiva S.A., a clinical-stage biopharmaceutical company, focuses on the development of oral small molecule therapies for the treatment of non-alcoholic steatohepatitis (NASH), mucopolysaccharidoses (MPS), and other diseases. Its lead product candidate is Lanifibranor, which has completed Phase IIb clinical trial to treat NASH. The company also develops Odiparcil, which has c...Show More
Earnings
Earnings Release in 17 daysEarnings per Share (Estimate*)
Revenue (Estimate*)
*Estimate based on analyst consensus